Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Upgrades PhenomeX to Equal-Weight, Announces $1 Price Target

Author: Benzinga Newsdesk | August 18, 2023 07:55am
Morgan Stanley analyst Tejas Savant upgrades PhenomeX (NASDAQ:CELL) from Underweight to Equal-Weight and announces $1 price target.

Posted In: CELL